[Bleeding complications due to anticoagulatoric therapy].

Der Internist
R MahnelC M Kirchmaier

Abstract

Anticoagulation is a standard treatment in patients with thrombosis and commonly used in surgical procedures for primary thrombosis prophylaxis. The occurrence of bleeding episodes is the predominant treatment complication. Although monitoring of hemostatic parameters reduces the risk of bleeding, bleedings occur in approximately 10% of patients. Besides standard life saving procedures it is crucial to ensure sufficient coagulation by administering factor concentrates (e.g. fresh frozen plasma, prothrombin complex, recombinant factor VIIa), platelet concentrates and fluid. Specific antidotes are not available for the majority of anticoagulant agents.

References

Apr 11, 2001·Circulation·B E LewisUNKNOWN ARG-911 Study Investigators
Jun 3, 2004·Annals of Internal Medicine·Harry R BüllerUNKNOWN Matisse Investigators
Jan 24, 2006·Seminars in Hematology·Heng Joo Ng, Mark A Crowther
Sep 12, 2006·Journal of Thrombosis and Haemostasis : JTH·F DentaliM Crowther
Nov 17, 2006·British Journal of Haematology·UNKNOWN British Committee for Standards in HaematologyP J Hamilton
Jun 27, 2008·The New England Journal of Medicine·Michael R LassenUNKNOWN RECORD3 Investigators
May 12, 2009·The American Journal of Cardiology·José G Díez, Marc Cohen
Jul 28, 2009·Journal of Thrombosis and Haemostasis : JTH·M Levi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.